Epidemiologic, clinical, and laboratory characteristics of childhood brucellosis : A study in an Iranian children's referral hospital.
Epidemiologische, klinische und Laborcharakteristika der kindlichen Brucellose : Eine Studie in einem iranischen Schwerpunkt-Kinderkrankenhaus.
Brucella
Children
Disease transmission, infectious
Epidemiology
Zoonotic diseases
Journal
Wiener medizinische Wochenschrift (1946)
ISSN: 1563-258X
Titre abrégé: Wien Med Wochenschr
Pays: Austria
ID NLM: 8708475
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
25
08
2018
accepted:
16
01
2019
pubmed:
20
2
2019
medline:
27
6
2019
entrez:
20
2
2019
Statut:
ppublish
Résumé
Brucellosis is endemic in Iran. Children constitute 20-25% of cases. We determined clinical, laboratory, and epidemiologic characteristics of pediatric brucellosis patients hospitalized at the Children's Medical Center from May 2011 to December 2016. Medical records were reviewed retrospectively. For each patient, a questionnaire was provided containing demographic characteristics (sex, age, nationality, date of admission, city of residence, history of ingestion of unpasteurized dairy products, family history of brucellosis, history of contact with suspicious animals) and clinical information (signs and symptoms, laboratory findings, history of disease relapse, treatment). Included were 43 patients diagnosed with brucellosis (26 males, 60.5%; age 1-13 years, mean ± SD: 7.02 ± 3.5). A history of ingestion of raw or unpasteurized dairy products was present in 88% (N = 38) and 11 patients (26%) had had contact with a suspicious animal. Highest frequencies of brucellosis were recorded in 2013 (N = 10, 23%) and 2015 (N = 11, 26%). Most cases were admitted in the summer (N = 14, 33%) and spring (N = 12, 28%). Fever (N = 39, 91%), arthralgia (N = 33, 77%), and malaise (N = 33, 77%) were the main complaints. Anemia (65%), lymphocytosis (51%), and elevated erythrocyte sedimentation rate (86%) and C‑reactive protein (67%) were the most prominent blood anomalies. Blood culture was positive in 30% (N = 11/37), bone marrow culture in 31% (N = 4/11). A positive Wright, Coombs Wright, and 2 ME test was observed in 67% (N = 29), 92% (N = 34/37), and 85% (N = 34/40) of cases, respectively. Median length of antibiotic therapy was 12 weeks (2-24 weeks). The most frequent drug regimen was combined trimethoprim-sulfamethoxazole and rifampicin (N = 24, 56%). Relapse occurred in 9 patients (21%), there were no deaths. Physicians should be aware of the manifestations, diagnosis, and treatment protocols of childhood brucellosis. Control programs and preventive measures, e.g., regular examination of domestic animals, mass vaccination of livestock, slaughter of infected animals, control of animal trade and migration, pasteurization of milk and milk products, training and increased public awareness of the dangers of consumption of unpasteurized dairy products, are highly recommended.
Sections du résumé
BACKGROUND
BACKGROUND
Brucellosis is endemic in Iran. Children constitute 20-25% of cases. We determined clinical, laboratory, and epidemiologic characteristics of pediatric brucellosis patients hospitalized at the Children's Medical Center from May 2011 to December 2016.
METHODS
METHODS
Medical records were reviewed retrospectively. For each patient, a questionnaire was provided containing demographic characteristics (sex, age, nationality, date of admission, city of residence, history of ingestion of unpasteurized dairy products, family history of brucellosis, history of contact with suspicious animals) and clinical information (signs and symptoms, laboratory findings, history of disease relapse, treatment).
RESULTS
RESULTS
Included were 43 patients diagnosed with brucellosis (26 males, 60.5%; age 1-13 years, mean ± SD: 7.02 ± 3.5). A history of ingestion of raw or unpasteurized dairy products was present in 88% (N = 38) and 11 patients (26%) had had contact with a suspicious animal. Highest frequencies of brucellosis were recorded in 2013 (N = 10, 23%) and 2015 (N = 11, 26%). Most cases were admitted in the summer (N = 14, 33%) and spring (N = 12, 28%). Fever (N = 39, 91%), arthralgia (N = 33, 77%), and malaise (N = 33, 77%) were the main complaints. Anemia (65%), lymphocytosis (51%), and elevated erythrocyte sedimentation rate (86%) and C‑reactive protein (67%) were the most prominent blood anomalies. Blood culture was positive in 30% (N = 11/37), bone marrow culture in 31% (N = 4/11). A positive Wright, Coombs Wright, and 2 ME test was observed in 67% (N = 29), 92% (N = 34/37), and 85% (N = 34/40) of cases, respectively. Median length of antibiotic therapy was 12 weeks (2-24 weeks). The most frequent drug regimen was combined trimethoprim-sulfamethoxazole and rifampicin (N = 24, 56%). Relapse occurred in 9 patients (21%), there were no deaths.
CONCLUSIONS
CONCLUSIONS
Physicians should be aware of the manifestations, diagnosis, and treatment protocols of childhood brucellosis. Control programs and preventive measures, e.g., regular examination of domestic animals, mass vaccination of livestock, slaughter of infected animals, control of animal trade and migration, pasteurization of milk and milk products, training and increased public awareness of the dangers of consumption of unpasteurized dairy products, are highly recommended.
Identifiants
pubmed: 30778882
doi: 10.1007/s10354-019-0685-z
pii: 10.1007/s10354-019-0685-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
232-239Références
Indian Pediatr. 2001 Dec;38(12):1421-5
pubmed: 11752745
Trop Doct. 2002 Apr;32(2):91-2
pubmed: 11931209
BMC Infect Dis. 2003 Apr 28;3:5
pubmed: 12718759
J Trop Pediatr. 2004 Jun;50(3):153-7
pubmed: 15233191
Pediatr Int. 2009 Feb;51(1):114-9
pubmed: 19371290
Int J Infect Dis. 2010 Jun;14(6):e469-78
pubmed: 19910232
Turk J Pediatr. 2010 Jul-Aug;52(4):426-9
pubmed: 21043393
BMC Infect Dis. 2010 Dec 09;10:346
pubmed: 21143881
Pediatr Hematol Oncol. 2011 Apr;28(3):203-8
pubmed: 21381870
Ann Saudi Med. 2011 May-Jun;31(3):270-3
pubmed: 21623056
Int J Infect Dis. 2011 Dec;15(12):e812-7
pubmed: 21893423
Turk J Pediatr. 2011 Jul-Aug;53(4):413-24
pubmed: 21980844
PLoS Negl Trop Dis. 2012;6(12):e1929
pubmed: 23236528
Iran J Pediatr. 2012 Sep;22(3):319-25
pubmed: 23399875
Clin Infect Dis. 2013 May;56(10):1407-12
pubmed: 23446629
Mediterr J Hematol Infect Dis. 2013;5(1):e2013011
pubmed: 23505599
J Health Popul Nutr. 2013 Jun;31(2):218-22
pubmed: 23930340
Curr Opin Infect Dis. 2013 Oct;26(5):404-12
pubmed: 23963260
J Microbiol Immunol Infect. 2015 Aug;48(4):446-9
pubmed: 25092047
Pediatr Int. 2015 Aug;57(4):586-9
pubmed: 25675977
Med Glas (Zenica). 2015 Aug;12(2):177-82
pubmed: 26276656
Asian Pac J Trop Med. 2015 Dec;8(12):1027-1032
pubmed: 26706674
Microb Pathog. 2017 Aug;109:239-247
pubmed: 28602839
Biomed Res Int. 2018 Apr 22;2018:5712920
pubmed: 29850535